Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | HTR6 | P50406 | 2/20 | 0.44 |
| ▸ | PSIP1 | O75475 | 1/20 | 0.43 |
| ▸ | PARL | Q9H300 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 5/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA3 | P07451 | 1/20 | 0.41 |
| ▸ | CA4 | P22748 | 1/20 | 0.41 |
| ▸ | CA6 | P23280 | 1/20 | 0.41 |
| ▸ | CA5A | P35218 | 1/20 | 0.41 |
| ▸ | CA7 | P43166 | 1/20 | 0.41 |
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Potassium SCHEMBL29397290 | 0.98 | ALDH1A1 (0.44) | ALDH1A1TDP1HSD17B10HTR6PSIP1 | |
| SCHEMBL29162254 | 0.98 | ALDH1A1 (0.44) | ALDH1A1TDP1HSD17B10HTR6PSIP1 | |
| SCHEMBL28494149 | 0.88 | PKM (0.36) | ALDH1A1TDP1MAPTCA12CA1 | |
| SCHEMBL14779088 | 0.86 | ALDH1A1 (0.46) | ALDH1A1TDP1HSD17B10HTR6PSIP1 | |
| SCHEMBL28499926 | 0.84 | CA1 (0.43) | ALDH1A1TDP1HSD17B10HTR6MAPT | |
| SCHEMBL28807218 | 0.83 | CA1 (0.49) | ALDH1A1MAPTKDM4EHPGDCA12 | |
| SCHEMBL12212901 | 0.82 | CA2 (0.41) | ALDH1A1HSD17B10PARLMAPTKDM4E | |
| SCHEMBL2057567 | 0.81 | ALDH1A1 (0.41) | ALDH1A1TDP1HSD17B10HTR6PSIP1 | |
| SCHEMBL2057882 | 0.81 | ALDH1A1 (0.42) | ALDH1A1TDP1HSD17B10HTR6PSIP1 | |
| SCHEMBL2057556 | 0.81 | ALDH1A1 (0.41) | ALDH1A1TDP1HSD17B10HTR6PSIP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 191 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025129550-A1 | POLYORGANOSILOXANE COMPOSITION | DOW SILICONES CORPORATION (US) | 2025-06-26 | — | — | WO | claimed |
| CN-118712492-A | Sodium ion battery electrolyte and preparation method and application thereof | 中国科学院大连化学物理研究所 | 2024-09-27 | — | — | CN | claimed |
| CN-118315668-A | Wide temperature range high voltage sodium ion battery electrolyte and sodium ion battery | 珠海钠壹新能源科技有限公司 | 2024-07-09 | — | — | CN | claimed |
| CN-111095656-B | Lithium secondary battery | 三星SDI株式会社 | 2024-03-22 | — | — | CN | claimed |
| CN-117577943-A | Electrolyte additive, electrolyte and battery | 广州天赐高新材料股份有限公司 | 2024-02-20 | — | — | CN | claimed |
| CN-115668459-A | Surface treatment method for semiconductor substrate and surface treatment agent composition | 中央硝子株式会社 | 2023-01-31 | — | — | CN | claimed |
| CN-109428110-B | Rechargeable lithium battery | 三星SDI株式会社 | 2022-04-29 | — | — | CN | claimed |
| CN-113072448-A | Aryl gemfibrozil derivative high-valence iodine compound and preparation method thereof | 五邑大学 | 2021-07-06 | — | — | CN | claimed |
| US-20200373617-A1 | LITHIUM SECONDARY BATTERY | SAMSUNG SDI CO., LTD. (KR) | 2020-11-26 | — | — | US | claimed |
| US-20200373616-A1 | LITHIUM SECONDARY BATTERY | SAMSUNG SDI CO., LTD. (KR) | 2020-11-26 | — | — | US | claimed |
| US-20050244719-A1 | Mixture containing sulfonate compound, lithium salt and nonaqueous solvent | SAMSUNG SDI CO., LTD. | 2005-11-03 | — | — | US | claimed |
| US-6696568-B2 | PARKINSON'S DISEASE | FINETECH LTD. (IL) | 2004-02-24 | — | — | US | claimed |
| EP-1379526-A1 | PROCESS AND INTERMEDIATES FOR PRODUCTION OF CABERGOLINE AND RELATED COMPOUNDS | Finetech Laboratories Ltd. (IL) | 2004-01-14 | — | — | EP | claimed |
| US-20020197537-A1 | Lithium salt; a nonaqueous solvent; and a sulfonate, sulfonyl halide, silyl sulfonate or disilyl sulfate; improved low temperature characteristics | PANAX ETEC CO., LTD. (KR) | 2002-12-26 | — | — | US | claimed |
| US-20020177709-A1 | Novel process and intermediates for production of cabergoline and related compounds | FINETECH PHARMACEUTICAL LTD. (IL) | 2002-11-28 | — | — | US | claimed |
| WO-2002085902-A1 | PROCESS AND INTERMEDIATES FOR PRODUCTION OF CABERGOLINE AND RELATED COMPOUNDS | FINETECH LABORATORIES LTD. (IL) | 2002-10-31 | — | — | WO | claimed |
| US-6093780-A | CONSISTS OF ALPHA-CYANOACRYLATE AND A THERMAL RESISTANCE CONFERRING COMPONENT SELECTED FROM THE ALKYLATING AGENT SUCH AS 4-NITROBENZYL CHLORIDE OR POLYVINYL BENZYL CHLORIDE AND A SILYLATING AGENT | LOCTITE CORPORATION (US) | 2000-07-25 | — | — | US | claimed |
| EP-0143323-B1 | PROCESS FOR AN ANTHRACYCLINE DERIVATIVE, AND AN ANTHRACYCLINONE DERIVATIVE USEFUL FOR THE PROCESS | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1988-10-26 | — | — | EP | claimed |
| US-4564674-A | Process for an anthracycline derivative, and an anthracyclinone derivative useful for the process | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1986-01-14 | — | — | US | claimed |
| EP-0143323-A2 | Process for an anthracycline derivative, and an anthracyclinone derivative useful for the process | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1985-06-05 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020177709-A1 | Novel process and intermediates for production of cabergoline and related compounds | NR5A1, ADCY5, GNRHR | ALDH1A1 2658/4885TDP1 3057/4885HSD17B10 1312/4885 |
| US-20200373617-A1 | LITHIUM SECONDARY BATTERY | SLC9B2, SLC9A1, SLC9A2 | ALDH1A1 1373/4885TDP1 2535/4885HSD17B10 935/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.